Viewing Study NCT03085095


Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2026-05-14 @ 11:51 PM
Study NCT ID: NCT03085095
Status: COMPLETED
Last Update Posted: 2022-01-18
First Post: 2017-03-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Sponsor: Myovant Sciences GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords: